Expressions of cyclin D1 and Ki-67 and their correlation with prognosis in esophageal squamous cell carcinoma

Chinese Journal of Cancer Prevention and Treatment

Volumn 15, Issue 4, 2008, Pages 276-279

  Sun, Ai Min ^a   Li, Dao Tang ^a   Mu, Dian Bin ^a   Li, Hui ^a   Luo, Jing Yu ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Carcinoma, squamous cell pathology; Cyclin D1; Esophageal neoplasms pathology; Ki 67 antigen; Prognosis

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

EID: 77953439549     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fu M, Wang C, Li Z, et al. Cyclin D1: normal and abnormal functions[J]. Endocrinology, 2004, 145(12): 5439-5447.
2. Chinese source.
3. Chinese source.
4. Langer R, Von-Rahden B H A, Nahrig J, et al. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, Cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study [J]. J Clin Pathol, 2006, 59(6): 631-634.
5. Shao J C, Wu J F, Wang D B, et al. Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance [J]. World J Gastroenterol, 2003, 9(3): 427-431.
6. Yang X D, Zuo M, Pan K. Expression and clinical significance of p27 protein and Cyclin D1 protein in gastrointestinal stromal tumors[J]. Zhonghua Yi Xue Za Zhi, 2005, 85(19): 1352-1354.
7. Papay J, Krenacs T, Moldvay J, et al. Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach[J]. Appl Immunohistochem Mol Morphol, 2007, 15(1): 19-30.
8. Kawakubo H, Ozawa S, Ando N, et al. Alterations of p53, Cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma [J]. Oncol Rep, 2005, 14(6): 1453-1459.
9. Wu M Y, Zhuang C X, Yang H X, et al. Expression of Egr-1, c-fos and Cyclin D1 in esophagealcancer and its precursors: An immunohistochemical and in situ hybridization study[J]. World J Gastroenterol, 2004, 10(4): 476-480.
10. Zhu S C, Li R, Wang Y X, et al. Impact of simultaneous assay, the PCNA, Cyclin D1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system [J]. World J Gastroenterol, 2005, 11(25): 3823-3829.
11. Kim D H, Muto M, Kuwahara Y, et al. Array-based comparative genomic hybridization of circulating esophageal tumor cells [J]. Oncol Rep, 2006, 16(5): 1053-1059.
12. Zhang J H, Li Y, Wang R, et al. Association of Cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population[J]. Int J Cancer, 2003, 10502): 281-284.
13. Naitoh H, Shibata J, Kawaguchi A, et al. Overexpression and localization of Cyclin D1 mRNA and antigen in esophageal cancer [J]. Am J Pathol, 1995, 146(5): 1161-1169.
14. Ishikawa T, Furihata M, Ohtsuki Y, et al. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squarnous cell carcinoma [J]. Br J Cancer, 1998, 77(1): 92-97.
15. Katzenberger T, Petzoldt C, Holler S, et al. The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma[J]. Blood, 2006, 107(8): 3407.